{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:32:20Z","timestamp":1740173540876,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Data"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Multiple Sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system, causing increased vulnerability to infections and disability among young adults. Ever since the outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 infections, there have been concerns among people with MS (PwMS) about the potential interactions between various disease-modifying therapies and COVID-19. The COVID-19 in MS Global Data Sharing Initiative (GDSI) was initiated in 2020 with the aim of addressing these concerns. This paper focuses on the anonymisation and publicly releasing of a GDSI sub-dataset, comprising data entered by PwMS and clinicians using a fast data entry tool. The dataset includes information on demographics, comorbidities and hospital stay and COVID-19 symptoms of PwMS. The dataset can be used to perform different statistical analyses to improve our understanding of COVID-19 in MS. Furthermore, this dataset can also be used within the context of educational activities to educate different stakeholders on the complex data science topics that were used within the GDSI.<\/jats:p>","DOI":"10.1038\/s41597-024-02978-x","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T11:02:31Z","timestamp":1706698951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient level dataset to study the effect of COVID-19 in people with Multiple Sclerosis"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0398-4848","authenticated-orcid":false,"given":"Hamza","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1919-9366","authenticated-orcid":false,"given":"Lotte","family":"Geys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peer","family":"Baneke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Comi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesbet M.","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,31]]},"reference":[{"key":"2978_CR1","first-page":"1935","volume":"70","author":"PA Calabresi","year":"2004","unstructured":"Calabresi, P. A. Diagnosis and management of multiple sclerosis. Am Fam Physician. 70, 1935\u20131944 (2004).","journal-title":"Am Fam Physician."},{"key":"2978_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/B978-0-444-52001-2.00009-1","volume":"122","author":"BAC Cree","year":"2014","unstructured":"Cree, B. A. C. Multiple sclerosis genetics. Handb Clin Neurol. 122, 193\u2013209 (2014).","journal-title":"Handb Clin Neurol."},{"key":"2978_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jneuroim.2009.05.002","volume":"212","author":"MN Hatch","year":"2009","unstructured":"Hatch, M. N., Schaumburg, C. S., Lane, T. E. & Keirstead, H. S. Endogenous remyelination is induced by transplant rejection in a viral model of multiple sclerosis. J Neuroimmunol. 212, 74\u201381 (2009).","journal-title":"J Neuroimmunol."},{"key":"2978_CR4","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1007\/s00415-022-11072-4","volume":"269","author":"M Vandebergh","year":"2022","unstructured":"Vandebergh, M., Degryse, N., Dubois, B. & Goris, A. Environmental risk factors in multiple sclerosis: bridging Mendelian randomization and observational studies. J Neurol. 269, 4565\u20134574 (2022).","journal-title":"J Neurol."},{"key":"2978_CR5","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/ene.12130","volume":"20","author":"S Montgomery","year":"2013","unstructured":"Montgomery, S., Hillert, J. & Bahmanyar, S. Hospital admission due to infections in multiple sclerosis patients. Eur J Neurol. 20, 1153\u20131160 (2013).","journal-title":"Eur J Neurol."},{"key":"2978_CR6","doi-asserted-by":"publisher","first-page":"e516","DOI":"10.1016\/S2589-7500(20)30217-X","volume":"2","author":"AS Yadaw","year":"2020","unstructured":"Yadaw, A. S. et al. Clinical features of COVID-19 mortality: development and validation of a clinical prediction model. Lancet Digit Health. 2, e516\u2013e525 (2020).","journal-title":"Lancet Digit Health."},{"key":"2978_CR7","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W Guan","year":"2020","unstructured":"Guan, W. et al. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine. 382, 1708\u20131720 (2020).","journal-title":"New England Journal of Medicine."},{"key":"2978_CR8","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson, S. et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 323, 2052\u20132059 (2020).","journal-title":"JAMA."},{"key":"2978_CR9","first-page":"557","volume":"43","author":"G Lamoureux","year":"1981","unstructured":"Lamoureux, G. et al. A clinical and immunological study of the effects of transfer factor on multiple sclerosis patients. Clin Exp Immunol. 43, 557\u2013564 (1981).","journal-title":"Clin Exp Immunol."},{"key":"2978_CR10","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1177\/1352458520941485","volume":"26","author":"LM Peeters","year":"2020","unstructured":"Peeters, L. M. et al. COVID-19 in people with multiple sclerosis: A global data sharing initiative. Mult Scler. 26, 1157\u20131162 (2020).","journal-title":"Mult Scler."},{"key":"2978_CR11","doi-asserted-by":"publisher","first-page":"e1870","DOI":"10.1212\/WNL.0000000000012753","volume":"97","author":"S Simpson-Yap","year":"2021","unstructured":"Simpson-Yap, S. et al. Associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis. Neurology. 97, e1870\u2013e1885 (2021).","journal-title":"Neurology."},{"key":"2978_CR12","doi-asserted-by":"publisher","DOI":"10.13026\/77ta-1866","author":"H Khan","year":"2024","unstructured":"Khan, H., Geys, L., Baneke, P, Comi, G. & Peeters, L. Patient-level dataset to study the effect of COVID-19 in people with multiple sclerosis. PhysioNet, https:\/\/doi.org\/10.13026\/77ta-1866 (2024)."},{"key":"2978_CR13","unstructured":"European Commission. Regulation (EU) 2016\/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95\/46\/EC (General Data Protection Regulation) (Text with EEA relevance). OJ. (2016)."},{"key":"2978_CR14","unstructured":"The OECD Glossary of Statistical Terms. https:\/\/stats.oecd.org\/glossary\/."},{"key":"2978_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1142\/S021848850200165X","volume":"10","author":"L Sweeney","year":"2002","unstructured":"Sweeney, L. Achieving k-anonymity privacy protection using generalization and suppression. International Journal of Uncertainty, Fuzziness and Knowledge-Based Systems. 10, 571\u2013588 (2002).","journal-title":"International Journal of Uncertainty, Fuzziness and Knowledge-Based Systems."},{"key":"2978_CR16","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3390\/s23031554","volume":"23","author":"B Su","year":"2023","unstructured":"Su, B. et al. K-Anonymity privacy protection algorithm for multi-dimensional data against skewness and similarity attacks. Sensors (Basel). 23, 1554 (2023).","journal-title":"Sensors (Basel)."},{"key":"2978_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1145\/1217299.1217302","volume":"1","author":"A Machanavajjhala","year":"2007","unstructured":"Machanavajjhala, A., Kifer, D., Gehrke, J. & Venkitasubramaniam, M. L-diversity: Privacy beyond k-anonymity. ACM Trans. Knowl. Discov. Data. 1, 3\u2013es (2007).","journal-title":"ACM Trans. Knowl. Discov. Data."},{"key":"2978_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-022-01335-0","volume":"9","author":"J Yperman","year":"2022","unstructured":"Yperman, J., Popescu, V., Van Wijmeersch, B., Becker, T. & Peeters, L. M. Motor evoked potentials for multiple sclerosis, a multiyear follow-up dataset. Sci Data 9, 207 (2022).","journal-title":"Sci Data"},{"key":"2978_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter, J. D. Matplotlib: A 2D graphics environment. Computing in Science & Engineering. 9, 90\u201395 (2007).","journal-title":"Computing in Science & Engineering."},{"key":"2978_CR20","doi-asserted-by":"publisher","unstructured":"team, T. pandas development. pandas-dev\/pandas: Pandas (v1.5.3), https:\/\/doi.org\/10.5281\/ZENODO.7549438 (2023).","DOI":"10.5281\/ZENODO.7549438"},{"key":"2978_CR21","unstructured":"Harris, C. Array programming with NumPy."},{"key":"2978_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen, P. et al. SciPy 1.0: Fundamental algorithms for scientific computing in Python. Nat Methods 17, 261\u2013272 (2020).","journal-title":"Nat Methods"},{"key":"2978_CR23","doi-asserted-by":"publisher","unstructured":"Kluyver, T. et al. Jupyter Notebooks \u2013 a publishing format for reproducible computational workflows. in (eds. Loizides, F. & Scmidt, B.) 87\u201390, https:\/\/doi.org\/10.3233\/978-1-61499-649-1-87 (IOS Press, 2016).","DOI":"10.3233\/978-1-61499-649-1-87"},{"key":"2978_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/NT.0000000000000092","volume":"50","author":"FQ Nuttall","year":"2015","unstructured":"Nuttall, F. Q. Body mass index. Nutr Today. 50, 117\u2013128 (2015).","journal-title":"Nutr Today."},{"key":"2978_CR25","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke, J. F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33, 1444\u20131452 (1983).","journal-title":"Neurology."},{"key":"2978_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-14-58","volume":"14","author":"S Meyer-Moock","year":"2014","unstructured":"Meyer-Moock, S., Feng, Y.-S., Maeurer, M., Dippel, F.-W. & Kohlmann, T. Systematic literature review and validity evaluation of the expanded disability status scale (EDSS) and the multiple sclerosis functional composite (MSFC) in patients with multiple sclerosis. BMC Neurol. 14, 58 (2014).","journal-title":"BMC Neurol."}],"container-title":["Scientific Data"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41597-024-02978-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41597-024-02978-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41597-024-02978-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T11:05:44Z","timestamp":1706699144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41597-024-02978-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2978"],"URL":"https:\/\/doi.org\/10.1038\/s41597-024-02978-x","relation":{"references":[{"id-type":"doi","id":"10.13026\/77ta-1866","asserted-by":"subject"}]},"ISSN":["2052-4463"],"issn-type":[{"type":"electronic","value":"2052-4463"}],"subject":[],"published":{"date-parts":[[2024,1,31]]},"assertion":[{"value":"1 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The operational costs linked to this study are funded by the Multiple Sclerosis International Federation (MSIF) and the Multiple Sclerosis Data Alliance (MS Data Alliance), acting under the umbrella of the European Charcot Foundation (ECF: ). The MS Data Alliance received income from a range of corporate sponsors, including Biogen, Bristol-Myers Squibb, Janssen Pharmaceuticals, Merck, Novartis, and Roche. MSIF also receives income from a number of corporate sponsors, recently including Biogen, Bristol-Myers Squibb, Coloplast, Janssen, Merck, Mylan, Novartis, Roche and Sanofi \u2013 all of which is publicly disclosed. In addition, the authors involved in this research have no conflicts of interest to report that are relevant to this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}